Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
The use of anticancer drugs to shrink or kill cancerous cells and reduce cancer spreading to other parts of the body.
To treat certain types of adult non-Hodgkins lymphoma that spread to the brain, CNS treatment (chemotherapy given to kill cancer cells in the brain or spinal cord) may be used. The way the chemotherapy is given depends on the type and stage of the cancer being treated.
Combination chemotherapy is treatment using two or more anticancer drugs. Steroid drugs may be added, to relieve swelling and inflammation, in addition to killing the lymphoma.
Targeted therapies can target cancerous cells without affecting healthy tissue, unlike radiation and chemotherapy treatments.
Monoclonal antibody therapy
Monoclonal antibody therapy is one type of targeted therapy used to treat adult non-Hodgkins lymphoma.
Monoclonal antibody therapy is a cancer treatment that uses antibodies made in the laboratory. These antibodies can identify substances on cancer cells or normal substances that may help cancer cells grow. The antibodies attach to the substances and kill the cancer cells, block their growth, or keep them from spreading. Monoclonal antibodies are given by infusion. They may be used alone or to carry drugs, toxins, or radioactive material directly to cancer cells. Monoclonal antibodies that have been joined to radioactive material are called radiolabeled monoclonal antibodies, such as Zevalin and Bexxar.
Non-Hodgkins lymphoma expertise
Stanford Lymphoma Program doctors commonly treat non-Hodgkins lymphoma with chemotherapy and radiation therapy, and also offer advanced therapies for patients, both adults and children, who will benefit from them. These state-of-the-art treatments include:
Peripheral blood and bone marrow transplants
Immunotherapy, such as rituximab
Radioimmunotherapy, such as Zevalin and Bexxar
Investigational treatments through clinical trials
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.